These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Nature and incidence of conditioned responses in a methadone population: a comparison of laboratory, clinic, and naturalistic settings. Childress AR; McLellan AT; O'Brien CP NIDA Res Monogr; 1986; 67():366-72. PubMed ID: 3092092 [No Abstract] [Full Text] [Related]
5. Conditioned tolerance in human opiate addicts. Ehrman R; Ternes J; O'Brien CP; McLellan AT Psychopharmacology (Berl); 1992; 108(1-2):218-24. PubMed ID: 1384078 [TBL] [Abstract][Full Text] [Related]
6. Classically conditioned responses in opioid and cocaine dependence: a role in relapse? Childress AR; McLellan AT; Ehrman R; O'Brien CP NIDA Res Monogr; 1988; 84():25-43. PubMed ID: 3147384 [TBL] [Abstract][Full Text] [Related]
7. Psychological and physiological response to hydromorphone: an opponent process view of addiction. Ternes JW; O'Brien CP NIDA Res Monogr; 1982 Apr; 41():497-503. PubMed ID: 6181413 [No Abstract] [Full Text] [Related]
8. Conditioned heroin responses as an indication of readdiction liability. Sideroff SI; Jarvik ME NIDA Res Monogr; 1979; 27():268-74. PubMed ID: 121343 [No Abstract] [Full Text] [Related]
9. Clinical treatment of opioid addiction and dependence. Ling W; Rawson RA; Compton M Methods Mol Med; 2003; 84():285-95. PubMed ID: 12703332 [No Abstract] [Full Text] [Related]
10. Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans. Bickel WK; Stitzer ML; Bigelow GE; Liebson IA; Jasinski DR; Johnson RE J Pharmacol Exp Ther; 1988 Oct; 247(1):47-53. PubMed ID: 2459370 [TBL] [Abstract][Full Text] [Related]
11. Role of conditioning factors in the development of drug dependence. Childress AR; McLellan AT; O'Brien CP Psychiatr Clin North Am; 1986 Sep; 9(3):413-25. PubMed ID: 3534813 [TBL] [Abstract][Full Text] [Related]
12. Comparison of buprenorphine and methadone effects on opiate self-administration in primates. Mello NK; Bree MP; Mendelson JH J Pharmacol Exp Ther; 1983 May; 225(2):378-86. PubMed ID: 6188822 [TBL] [Abstract][Full Text] [Related]
13. Assessment and extinction of conditioned withdrawal-like responses in an integrated treatment for opiate dependence. Childress AR; McLellan AT; O'Brien CP NIDA Res Monogr; 1984; 55():202-10. PubMed ID: 6443380 [TBL] [Abstract][Full Text] [Related]
14. Butorphanol-precipitated withdrawal in opioid-dependent human volunteers. Preston KL; Bigelow GE; Liebson IA NIDA Res Monogr; 1987; 76():157-61. PubMed ID: 2449617 [No Abstract] [Full Text] [Related]
15. Three-choice drug discrimination in opioid-dependent humans: hydromorphone, naloxone and saline. Preston KL; Bigelow GE; Bickel W; Liebson IA J Pharmacol Exp Ther; 1987 Dec; 243(3):1002-9. PubMed ID: 2447262 [TBL] [Abstract][Full Text] [Related]
16. Rationale for maintenance pharmacotherapy of opiate dependence. Kreek MJ Res Publ Assoc Res Nerv Ment Dis; 1992; 70():205-30. PubMed ID: 1346939 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of buprenorphine and methadone on opiate self-administration in primates. Mello NK; Bree MP; Mendelson JH NIDA Res Monogr; 1982 Apr; 41():67-73. PubMed ID: 6181414 [No Abstract] [Full Text] [Related]
18. Psychiatric symptoms in HIV test consenters and refusers. Woody G; Metzger DS; McLellan AT; O'Brien CP; DiPhilipis D NIDA Res Monogr; 1989; 95():415-6. PubMed ID: 2641015 [No Abstract] [Full Text] [Related]
19. Physiological and subjective effects of hydromorphone in postaddict volunteers. McCaul M; Stitzer M; Bigelow G; Liebson I NIDA Res Monogr; 1982 Apr; 41():301-8. PubMed ID: 6181412 [No Abstract] [Full Text] [Related]
20. Update of naltrexone treatment. O'Brien CP; Greenstein R; Woody GE NIDA Res Monogr; 1978; (19):315-20. PubMed ID: 218107 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]